T. Fornander

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “316P Differential long-term benefit of 2-year adjuvant tamoxifen therapy for luminal-type breast cancer: Insights from a 20-year follow-up analysis of the STO trials”.

316P Differential long-term benefit of 2-year adjuvant tamoxifen therapy for luminal-type breast cancer: Insights from a 20-year follow-up analysis of the STO trials

Annals of Oncology(2024)10.1016/j.annonc.2024.08.257

N/A

0DataRank · unranked

0 citations

Olof Danielsson, T. Fornander, Agneta Nordenskjöld, G. Pérez Tenorio, N.P. Tobin +6 more

315P Long-term tamoxifen benefit in pre- and postmenopausal patients of high and low risk with luminal A and B breast cancer

Annals of Oncology(2024)10.1016/j.annonc.2024.08.256

N/A

0DataRank · unranked

0 citations

Huma Dar, Agneta Nordenskjöld, G. Pérez Tenorio, CC Yau, CC Benz +9 more